Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. D-(+)-trehalose Dihydrate
2. 6138-23-4
3. D-trehalose Dihydrate
4. Alpha,alpha-trehalose Dihydrate
5. A,a-trehalose
6. Trehalose, Dihydrate
7. 7yin7j07x4
8. (2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-3,4,5-triol;dihydrate
9. Mfcd00071594
10. (2r,2'r,3s,3's,4s,4's,5r,5'r,6r,6'r)-6,6'-oxybis(2-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol) Dihydrate
11. Unii-7yin7j07x4
12. Alp,alp.-trehalose
13. Mycose Dihydrate
14. A,a-trehalose Dihydrate
15. Dextro-trehalose Dihydrate
16. Dsstox_cid_27948
17. Dsstox_rid_82700
18. Dsstox_gsid_47972
19. Schembl166078
20. Chembl3188936
21. Dtxsid3047972
22. Fema No. 4600
23. Trehalose Dihydrate [mi]
24. Alpha-d-glucopyranoside, Alpha-d-glucopyranosyl, Dihydrate
25. Trehalose Dihydrate, Cell Culture
26. Hms3885g16
27. Tox21_201106
28. Trehalose Dihydrate [who-dd]
29. A-d-glucopyranosyl-a-d-glucopyranoside
30. Akos016010526
31. Ccg-268385
32. Ncgc00258658-01
33. As-11785
34. Bp-20564
35. Trehalose Dihydrate [ep Monograph]
36. Cas-6138-23-4
37. D-(+)-trehalose Dihydrate, P.a., 99%
38. 2,2'-(1,6-hexanediyldioxy)bisbenzaldehyde
39. Alp.-d-glucopyranosyl-alp.-d-glucopyranoside
40. S3992
41. .alpha., .alpha.-trehalose Dihydrate
42. D70602
43. A833195
44. D-(+)-trehalose Dihydrate, From Starch, >=99%
45. D-trehalose Dihydrate 1000 Microg/ml In Acetonitrile
46. Q27269028
47. D-(+)-trehalose Dihydrate, For Microbiology, >=99.0%
48. D-(+)-trehalose Dihydrate, Saj Special Grade, >=99.0%
49. D-(+)-trehalose Dihydrate, Vetec(tm) Reagent Grade, >=99%
50. Trehalose, United States Pharmacopeia (usp) Reference Standard
51. .alpha.-d-glucopyranosyl-.alpha.-d-glucopyranoside Dihydrate
52. D-(+)-trehalose Dihydrate, From Saccharomyces Cerevisiae, >=99%
53. Trehalose Dihydrate, European Pharmacopoeia (ep) Reference Standard
54. D-(+)-trehalose Dihydrate, From Saccharomyces Cerevisiae, >=98.5% (hplc)
55. Trehalose, Pharmaceutical Secondary Standard; Certified Reference Material
56. D-(+)-trehalose Dihydrate (d-trehalose Dihydrate; Alpha,alpha-trehalose Dihydrate)
57. (2r,2'r,3s,3's,4s,4's,5r,5'r,6r,6'r)-6,6'-oxybis(2-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol)dihydrate
58. (2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-3,4,5-triol
59. 2-(hydroxymethyl)-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-3,4,5-triol Dihydrate
60. 2-(hydroxymethyl)-6-[3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-3,4,5-triol Dihydrate;d-(+)-trehalose Dihydrate
61. D-(+)-trehalose Dihydrate, From Saccharomyces Cerevisiae, Bioreagent, Plant Cell Culture Tested
62. D-(+)-trehalose Dihydrate, From Saccharomyces Cerevisiae, Powder, Bioreagent, Suitable For Cell Culture, Suitable For Insect Cell Culture, >=99%
| Molecular Weight | 378.33 g/mol |
|---|---|
| Molecular Formula | C12H26O13 |
| Hydrogen Bond Donor Count | 10 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 4 |
| Exact Mass | 378.13734088 g/mol |
| Monoisotopic Mass | 378.13734088 g/mol |
| Topological Polar Surface Area | 192 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 348 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 10 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Market Place
ABOUT THIS PAGE
A Trehalose Dihydrate API manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trehalose Dihydrate API, including repackagers and relabelers. The FDA regulates Trehalose Dihydrate API manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trehalose Dihydrate API API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Trehalose Dihydrate API manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Trehalose Dihydrate API supplier is an individual or a company that provides Trehalose Dihydrate API active pharmaceutical ingredient (API) or Trehalose Dihydrate API finished formulations upon request. The Trehalose Dihydrate API suppliers may include Trehalose Dihydrate API API manufacturers, exporters, distributors and traders.
click here to find a list of Trehalose Dihydrate API suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Trehalose Dihydrate API DMF (Drug Master File) is a document detailing the whole manufacturing process of Trehalose Dihydrate API active pharmaceutical ingredient (API) in detail. Different forms of Trehalose Dihydrate API DMFs exist exist since differing nations have different regulations, such as Trehalose Dihydrate API USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Trehalose Dihydrate API DMF submitted to regulatory agencies in the US is known as a USDMF. Trehalose Dihydrate API USDMF includes data on Trehalose Dihydrate API's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Trehalose Dihydrate API USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Trehalose Dihydrate API suppliers with USDMF on PharmaCompass.
Trehalose Dihydrate API Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trehalose Dihydrate API GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trehalose Dihydrate API GMP manufacturer or Trehalose Dihydrate API GMP API supplier for your needs.
A Trehalose Dihydrate API CoA (Certificate of Analysis) is a formal document that attests to Trehalose Dihydrate API's compliance with Trehalose Dihydrate API specifications and serves as a tool for batch-level quality control.
Trehalose Dihydrate API CoA mostly includes findings from lab analyses of a specific batch. For each Trehalose Dihydrate API CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trehalose Dihydrate API may be tested according to a variety of international standards, such as European Pharmacopoeia (Trehalose Dihydrate API EP), Trehalose Dihydrate API JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trehalose Dihydrate API USP).
LOOKING FOR A SUPPLIER?
